Daniel Meron is Director, Equity Research, and a Technology Analyst at RBC Capital Markets. He brings extensive research experience of over 15 years to his analysis of emerging technologies in communications, software and security. He was

Daniel Meron is Director, Equity Research, and a Technology Analyst at RBC Capital Markets. He brings extensive research experience of over 15 years to his analysis of emerging technologies in communications, software and security. He was ranked by the Financial Times/StarMine as number three Stock Picker in Software for 2011, number three Best Investment Returns in Israel by Globes for 2012, Ranked Best Technology Analyst in a survey of Israeli institutional investors (TheMarker, 2005) and featured as "Analyst on Target" (Calcalist, 2011)... More
Published April 26, 2014 in Biotechnology and Pharmaceuticals
Buy ($75)"We’re a faith-based and socially responsible investing firm"
Published May 16, 2013 in Investing in Health Care
Buy ($75)"The fund is about $40 million in assets"
Published May 16, 2013 in Investing in Health Care
Buy ($75)Published May 14, 2013 in High-Yield Equity Securities
Buy ($75)Published May 16, 2013
Published May 10, 2013
Published May 10, 2013